Skip to main content
. 2022 Oct 11;95(1140):20220106. doi: 10.1259/bjr.20220106

Table 1.

Patients’ clinical Characteristics and Computerized Tomographic Measurements According to the Presence of HsPE

Variable All patients
(n = 208)
Hemodynamically insignificant effusion
(n = 186)
Hemodynamically significant effusion
(n = 22)
P-Value
Age, ya 71 (57.5–79.2) 71.6 (59.6–80.2) 58.6 (47–72.7) .006
Male sex 90 (43) 83 (45) 7 (32) .252
Lung disease 35 (17) 35 (19) 0 .014
Ischemic heart disease 47 (23) 46 (25) 1 (5) .021
Atrial fibrillation 36 (17) 36 (19) 0 .012
CHF 44 (21) 43 (23) 1 (5) .03
Active malignancy 46 (22) 35 (19) 11 (50) .002
Hypertension 113 (54) 105 (57) 8 (36) .074
Hyperlipidemia 67 (32) 62 (33) 5 (23) .314
Active smoker 28 (14) 24 (13) 4 (18) .341
Chronic renal failure 7 (3) 6 (3) 1 (5) .548
Diabetes mellitus 49 (24) 47 (25) 2 (9) .091
LV volume 70.1 (53.2–94.1) 72 (55.9–95.2) 45.9 (36–70.5) < .001
LA volume 78.2 (55–112.5) 82.3 (58.6–115.9) 50.3 (37–57.1) < .001
RV volume 110.4 (82.4–147.7) 115.1 (87.4–150) 78.8 (72.4–89.1) < .001
RA volume 91 (68.9–129.6) 96.4 (73.1–135.3) 56.5 (50.9–75.4) < .001
LV volume index 39.9 (30.4–52.7) 40.8 (32.5–53.4) 27.1 (22.8–39.6) < .001
LA volume index 44.8 (31.4–65) 48 (33.4–66.5) 27.9 (22.1–32.7) < .001
RV volume index 61.6 (48.3–83.3) 65.3 (50.6–86.3) 44.4 (37.9–50.2) < .001
RA volume index 50.4 (39.4–76.5) 56 (41.4–80.1) 33.1 (28.8–41.6) < .001
VVR 2.7 (2.2–3.6) 2.8 (2.2–3.7) 2.5 (2–3.5) .361
AVR 2 (1.5–2.8) 2.1 (1.5–2.8) 1.9 (1.6–2.5) .495
Effusion size by CT, n (%)
 Small 106 (51) 105 (56) 1 (5) < .001
 Moderate or greater 102 (49) 81 (44) 21 (95)

AVR, atrium volume ratio; CT, computerized tomography; HsPE, hemodynamic significant pericardial effusion; LA, left atrium; LV, left ventricle; RA, right atrium; RV, right ventricle; VVR, ventricular volume ratio.

Volume is given in ml, and volume index is represented in ml/m².

a

Median and interquartile range. All other values represent the number of patients and percentages.